These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16135725)

  • 1. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor.
    Casas A; Gómez FP; Dahlén B; Roca J; Barberà JA; Dahlén SE; Rodríguez-Roisin R
    Eur Respir J; 2005 Sep; 26(3):442-8. PubMed ID: 16135725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
    Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
    Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
    Schelfhout V; Van De Velde V; Pauwels R; Joos G
    Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
    Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
    J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
    Crimi N; Pagano C; Palermo F; Mastruzzo C; Prosperini G; Pistorio MP; Vancheri C
    J Allergy Clin Immunol; 2003 Apr; 111(4):833-9. PubMed ID: 12704366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
    Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene E
    Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
    J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
    Guan WJ; Shi X; Zheng JP; Gao Y; Jiang CY; Xie YQ; Liu QX; Zhu Z; Guo E; An JY; Yu XX; Liu WT; Zhong NS
    Clin Respir J; 2015 Jan; 9(1):111-20. PubMed ID: 24506412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction.
    Steinshamn S; Sandsund M; Sue-Chu M; Bjermer L
    Scand J Med Sci Sports; 2002 Aug; 12(4):211-7. PubMed ID: 12199869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility.
    Corriveau S; Rousseau É; Blouin S; Pasquier JC
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():77-83. PubMed ID: 24735655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
    Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
    Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.
    Underwood DC; Osborn RR; Newsholme SJ; Torphy TJ; Hay DW
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):850-7. PubMed ID: 8887574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.